BioTelemetry, Inc. 4

Accession 0001209191-17-016191

CIK 0001574774operating

View on SEC.gov Company Profile

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 8:36 PM ET

Size

72.3 KB

Accession

0001209191-17-016191

Insider Transaction Report

Form 4

Period: 2017-02-27

BioTelemetry, Inc.BEAT

Hrenko George

SVP - Human Resources

Transactions

Exercise/Conversion
Stock Options
2017-02-27−2,654→ 0 total
Exercise: $10.36From: 2015-12-31Exp: 2025-02-16→ Common Stock (2,654 underlying)
Sale
Common Stock
2017-02-27$25.95/sh−7,500$194,625→ 20,518 total
Exercise/Conversion
Common Stock
2017-02-27$8.68/sh+9,211$79,951→ 29,729 total
Exercise/Conversion
Common Stock
2017-02-27$2.80/sh+38,495$107,786→ 59,013 total
Exercise/Conversion
Common Stock
2017-02-27$4.67/sh+15,000$70,050→ 35,518 total
Sale
Common Stock
2017-02-27$25.95/sh−15,000$389,250→ 20,518 total
Exercise/Conversion
Common Stock
2017-02-27$4.67/sh+12,953$60,491→ 33,471 total
Exercise/Conversion
Common Stock
2017-02-27$8.79/sh+4,077$35,837→ 24,595 total
Sale
Common Stock
2017-02-27$25.95/sh−4,077$105,798→ 20,518 total
Exercise/Conversion
Common Stock
2017-02-27$6.95/sh+7,500$52,125→ 28,018 total
Exercise/Conversion
Common Stock
2017-02-27$6.95/sh+2,500$17,375→ 23,018 total
Exercise/Conversion
Common Stock
2017-02-27$23.58/sh+2,900$68,382→ 23,418 total
Exercise/Conversion
Stock Options
2017-02-27−416→ 0 total
Exercise: $8.68From: 2014-12-31Exp: 2024-02-14→ Common Stock (416 underlying)
Exercise/Conversion
Common Stock
2017-02-27$10.36/sh+4,876$50,515→ 25,394 total
Exercise/Conversion
Common Stock
2017-02-27$8.68/sh+416$3,611→ 20,934 total
Sale
Common Stock
2017-02-27$25.95/sh−9,211$239,025→ 20,518 total
Sale
Common Stock
2017-02-27$25.95/sh−822$21,331→ 20,518 total
Exercise/Conversion
Common Stock
2017-02-27$2.54/sh+24,639$62,583→ 45,157 total
Exercise/Conversion
Stock Options
2017-02-27−12,953→ 0 total
Exercise: $4.67From: 2011-12-31Exp: 2021-03-04→ Common Stock (12,953 underlying)
Exercise/Conversion
Stock Options
2017-02-27−15,000→ 0 total
Exercise: $4.67From: 2012-03-11Exp: 2021-03-04→ Common Stock (4.67 underlying)
Exercise/Conversion
Stock Options
2017-02-27−9,211→ 0 total
Exercise: $8.68From: 2014-12-31Exp: 2024-02-14→ Common Stock (9,211 underlying)
Sale
Common Stock
2017-02-27$25.95/sh−2,654$68,871→ 20,518 total
Sale
Common Stock
2017-02-27$25.95/sh−416$10,795→ 20,518 total
Exercise/Conversion
Stock Options
2017-02-27−4,077→ 0 total
Exercise: $8.79From: 2010-12-31Exp: 2020-05-10→ Common Stock (4,077 underlying)
Exercise/Conversion
Stock Options
2017-02-27−38,495→ 0 total
Exercise: $2.80From: 2012-12-31Exp: 2022-02-21→ Common Stock (38,495 underlying)
Exercise/Conversion
Common Stock
2017-02-27$10.36/sh+2,654$27,495→ 23,172 total
Sale
Common Stock
2017-02-27$25.95/sh−4,876$126,532→ 20,518 total
Exercise/Conversion
Common Stock
2017-02-27$2.54/sh+822$2,088→ 21,340 total
Sale
Common Stock
2017-02-27$25.95/sh−24,639$639,382→ 20,518 total
Sale
Common Stock
2017-02-27$25.95/sh−38,495$998,945→ 20,518 total
Sale
Common Stock
2017-02-27$25.95/sh−12,953$336,130→ 20,518 total
Exercise/Conversion
Stock Options
2017-02-27−2,900→ 0 total
Exercise: $23.58From: 2009-12-15Exp: 2019-03-04→ Common Stock (2,900 underlying)
Exercise/Conversion
Stock Options
2017-02-27−2,500→ 0 total
Exercise: $6.95From: 2013-08-12Exp: 2019-08-12→ Common Stock (2,500 underlying)
Exercise/Conversion
Stock Options
2017-02-27−7,500→ 0 total
Exercise: $6.95From: 2010-08-12Exp: 2019-08-12→ Common Stock (7,500 underlying)
Exercise/Conversion
Stock Options
2017-02-27−822→ 0 total
Exercise: $2.54From: 2013-12-31Exp: 2023-02-19→ Common Stock (822 underlying)
Sale
Common Stock
2017-02-27$25.95/sh−2,500$64,875→ 20,518 total
Sale
Common Stock
2017-02-27$25.95/sh−2,900$75,255→ 20,518 total
Exercise/Conversion
Stock Options
2017-02-27−24,639→ 0 total
Exercise: $2.54From: 2013-12-31Exp: 2023-02-19→ Common Stock (24,693 underlying)
Exercise/Conversion
Stock Options
2017-02-27−4,876→ 0 total
Exercise: $10.36From: 2014-12-31Exp: 2025-02-16→ Common Stock (4,876 underlying)

Footnotes (2)

[F1]Represents sales pursuant to the reporting person's retirement.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.60 to $26.30, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth this Form 4.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

BioTelemetry, Inc.

CIK 0001574774

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0001574774

Filing Metadata

Form type: 4
Filed: Feb 28, 7:00 PM ET
Accepted: Mar 1, 8:36 PM ET
Size: 72.3 KB

View on SEC.gov